Evaluation of Prognostic Factors Following Flow-Cytometric DNA Analysis after Cytokeratin Labelling: II. Cervical and Endometrial Cancer

Evaluation of Prognostic Factors Following Flow-Cytometric DNA Analysis after Cytokeratin Labelling: II. Cervical and Endometrial Cancer

In gynecologic oncology valid prognostic factors are necessary to define biologically similar subgroups for analysis of therapeutic efficacy. This study is the first published prospective study concerning prognostic significance of DNA ploidy and S‐phase fraction in cervical and endometrial cancer f...

Full description

Bibliographic Details
Main Authors:	Pauline Wimberger, Peter Hillemanns, Thomas Kapsner, Hermann Hepp, Rainer Kimmig
Format:	Article
Language:	English
Published:	Hindawi Limited 2002-01-01
Series:	Analytical Cellular Pathology
Online Access:	http://dx.doi.org/10.1155/2002/346969

Similar Items

Evaluation of Prognostic Factors Following Flow-Cytometric DNA Analysis after Cytokeratin Labelling: I. Breast Cancer
by: Pauline Wimberger, et al.
Published: (2002-01-01)

Flow Cytometric DNA Analysis Using Cytokeratin Labeling for Identification of Tumor Cells in Carcinomas of the Breast and the Female Genital Tract
by: Rainer Kimmig, et al.
Published: (2001-01-01)

Flow Cytometric Bivariate Analysis of DNA and Cytokeratin in Colorectal Cancer
by: Carolin Post, et al.
Published: (2002-01-01)

Biological Characterisation of Superficial Bladder Cancer by Bivariate Cytokeratin 7/DNA Analysis, Flow Cytometric Assessment of MIB-1, and an Immunohistochemical Study
by: Elena Leonardi, et al.
Published: (2000-01-01)

Erratum to: Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis
by: Hojung Lee, et al.
Published: (2017-05-01)

The analysis of flow cytometric DNA data
by: Shahran, M. K.
Published: (1986)

Predictive Value of Serum Cytokeratin 19 Level for the Feasibility of Conserving Ovaries in Endometrial Cancer
by: Jie Xu, et al.
Published: (2021-08-01)

Non Hodgkins lymphoma : prognostic factors including the measurement of DNA content by flow cytometric analysis
by: Cowan, Richard A.
Published: (1990)

LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
by: Kuhlmann Jan, et al.
Published: (2012-07-01)

Cytokeratin7 expression in gastric and colorectal adenocarcinoma: Correlation with prognostic factors
by: Mohammadreza Jalalinadoushan, et al.
Published: (2015-10-01)

Cytokeratins Tools in Oncology
Published: (2012)

Cytometric DNA Analysis and Prognostic Biomarkers in Breast Carcinoma. Expression of P53 Product in the Different Ploidy Classes
by: Elena Leonardi, et al.
Published: (1997-01-01)

Expression of cytokeratins 8 and 17 as a diagnostic marker of cervical intraepithelial neoplasia
by: Kalodimos George, et al.
Published: (2010-01-01)

Cytologic and DNA-Cytometric Early Diagnosis of Oral Cancer
by: Torsten W. Remmerbach, et al.
Published: (2001-01-01)

DNA-cytometric characteristics of recurrent soft tissue sarcomas
by: E M Nepomnyashchaya, et al.
Published: (2018-06-01)

Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma
by: Ivković-Kapicl Tatjana, et al.
Published: (2012-01-01)

Flow-cytometric DNA content and S-phase fraction values as a prognostic factor on nasopharyngeal cancer - a preliminary report
by: S. Gondhowiardjo, et al.
Published: (1997-01-01)

Stem cell markers (cytokeratin 17 and cytokeratin 19) in scarring and nonscarring alopecia
by: Dalia El Sakka, et al.
Published: (2016-01-01)

Cytokeratin 7 negative and cytokeratin 20 positive orbital metastatic breast carcinoma
by: Sabrina Bergeron, MSc, et al.
Published: (2018-06-01)

Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis.
by: Dong Cen, et al.
Published: (2017-01-01)

Implementation of an in-house flow cytometric analysis of DNA fragmentation in spermatozoa
by: Anne Sofie Rex, et al.
Published: (2020-01-01)

DNA flow cytometric analysis in variable types of hydropic placentas
by: Fatemeh Atabaki pasdar, et al.
Published: (2015-05-01)

Flow Cytometric DNA Index and Karyotype in Childhood Lymphoblastic Leukemia
by: Erik Forestier, et al.
Published: (1998-01-01)

Multifunctional substrate of label-free electrochemical immunosensor for ultrasensitive detection of cytokeratins antigen 21-1
by: Huiqiang Wang, et al.
Published: (2017-04-01)

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
by: Gian Paolo Caviglia, et al.
Published: (2020-09-01)

Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors
by: Eun-Mi Son, et al.
Published: (2015-01-01)

Prognostic Implications of Immune-Related Genes’ (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer
by: Hao Ding, et al.
Published: (2020-07-01)

Cytokeratin expression in corneal dystrophies
by: Anamaria Baptista Coutinho, et al.
Published: (2011-04-01)

Prediction of prognosis in human breast cancer : a study on clinicopathologic and cytometric prognostic factors
by: Arnerlöv, Conny
Published: (1991)

Predictors for the Recurrence of Clinically Uterine‐Confined Endometrial Cancer and the Role of Cytokeratin Immunohistochemistry Stain in the Era of Sentinel Lymph Node Mapping
by: Chen, H.-H, et al.
Published: (2022)

Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
by: Jaudah Al-Maghrabi, et al.
Published: (2018-01-01)

Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers
by: María Milagros Otero-García, et al.
Published: (2019-02-01)

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
by: Weiwei Feng, et al.
Published: (2021-02-01)

Serum level of cytokeratin 19 as a diagnostic and prognostic marker in patients with HCV-related hepatocellular carcinoma
by: Maissa El Raziky, et al.
Published: (2021-06-01)

Serum cytokeratin-19 fragment (Cyfra 21-1) is a prognostic indicator for epithelial ovarian cancer
by: Hua-Hsi Wu, et al.
Published: (2014-03-01)

Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers
by: Bernreuther, C., et al.
Published: (2022)

Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors
by: Anne Menz, et al.
Published: (2021-02-01)

A multi-parametric flow cytometric assay to analyze DNA-protein interactions
by: Arbab, Mandana, et al.
Published: (2013)

Cytokeratin 20-positive hepatocellular carcinoma
by: G. Faa, et al.
Published: (2009-12-01)

Cytokeratin 20-positive hepatocellular carcinoma
by: D. Fanni, et al.
Published: (2009-12-01)

Cannot write session to /tmp/vufind_sessions/sess_4qigr90555l01pnbuacq28svda